Back to search

Peptide record

TPDB03231

Antibacterial Anticancer Hemolysis Toxicity standard
22 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB03231
Antibacterial Anticancer Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia PD_Hemolysis
standard
No
A 22-aa standard natural multi-activity (Antibacterial, Anticancer, Hemolysis, and other sources) peptide sequence curated from AntiBP3, Peptipedia, and PD_Hemolysis, with an available 3D structural model.
Sequence
MQFITDLIKKAVDVFKGLFGNK
Physicochemical Analysis
C118H190N28O30S1
RCEHPSWY
K
2513.04
10.16
4
2
11
+2
2.19
0.273
101.82
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
3
Residue Composition
number
1
A
0
R
1
N
2
D
0
C
0
E
1
Q
2
G
0
H
2
I
2
L
4
K
1
M
3
F
0
P
0
S
1
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 1 R: 0 N: 1 D: 2 C: 0 E: 0 Q: 1 G: 2 H: 0 I: 2 L: 2 K: 4 M: 1 F: 3 P: 0 S: 0 T: 1 W: 0 Y: 0 V: 2
Chemical Descriptors
22
C118H190N28O30S1
2513.04
10.16
+2
2.19
0.273
Evidence Records 3 records
Evidence 1 Activity

Activity

10% Hemolysis
Toxicity
12.5 µM
Hemolytic Cytotoxic
10% Hemolysis | 12.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Evidence 2 Activity

Activity

% Hemolysis
Toxicity
10 %
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes:10% Hemolysis=12.5µM | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
PLoS One. 2016 Sep 6 11(9):e0162007.
Evidence 3 Hemolysis

Source & Reference

PD_Hemolysis
PD_Hemolysis